-
1.
公开(公告)号:US11439696B2
公开(公告)日:2022-09-13
申请号:US15756282
申请日:2016-08-29
IPC分类号: A61K39/00 , A61K39/395 , C07K16/18 , G01N33/543 , A61K39/39 , C07K14/47 , A61K38/17 , C12N9/58 , A61P3/06
摘要: The patent application pertains to compositions and methods for reducing Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) expression and for reducing serum cholesterol in mammalian subjects. The exemplary compositions comprise heat0 shock protein HSP27 or fragments thereof and/or a HSP25, or fragments thereof in a mixture with an adjuvant. The compositions may optionally comprise anti-HSP27 antibody. The method for reducing serum cholesterol relate to the use of the compositions to increase the subject's levels of serum HSP27 and/or anti-HSP27 antibodies.
-
2.
公开(公告)号:US12005101B2
公开(公告)日:2024-06-11
申请号:US17515001
申请日:2021-10-29
IPC分类号: A61K39/00 , A61K38/17 , A61K39/39 , A61K39/395 , A61P3/06 , C07K14/47 , C07K16/18 , C12N9/58 , G01N33/543
CPC分类号: A61K39/0005 , A61K38/1709 , A61K39/39 , A61K39/3955 , A61P3/06 , C07K14/47 , C07K14/4703 , C07K16/18 , C12N9/58 , G01N33/54326 , A61K39/395 , A61K2039/55505 , A61K2039/55566 , G01N2333/4703
摘要: This disclosure pertains to compositions and methods for reducing serum cholesterol in mammalian subjects. The exemplary compositions comprise mixtures of HSP27 protein or fragments thereof, a HSP25 protein or fraction thereof, a recombinant rHSP25 peptide, or a recombinant HSP27 peptide in a mixture with an adjuvant. The compositions may optionally comprise anti-HSP27 antibody. The methods for reducing serum cholesterol in mammalian subjects relate to the use of the compositions to increase the subjects' levels of serum HSP27 and/or anti-HSP27 antibodies.
-
3.
公开(公告)号:US20220118068A1
公开(公告)日:2022-04-21
申请号:US17515001
申请日:2021-10-29
IPC分类号: A61K39/00 , C07K16/18 , G01N33/543 , A61K39/39 , C07K14/47 , A61K38/17 , C12N9/58 , A61P3/06 , A61K39/395
摘要: This disclosure pertains to compositions and methods for reducing serum cholesterol in mammalian subjects. The exemplary compositions comprise mixtures of HSP27 protein or fragments thereof, a HSP25 protein or fraction thereof, a recombinant rHSP25 peptide, or a recombinant HSP27 peptide in a mixture with an adjuvant. The compositions may optionally comprise anti-HSP27 antibody. The methods for reducing serum cholesterol in mammalian subjects relate to the use of the compositions to increase the subjects' levels of serum HSP27 and/or anti-HSP27 antibodies.
-
-